The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10146 malaria professionals are enjoying the free benefits of MalariaWorld today

artemether–lumefantrine (AL)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017

June 24, 2019 - 16:00 -- Open Access
Author(s): 
Benjamin Abuaku, Nancy O. Duah-Quashie, Lydia Quaye, Sena A. Matrevi, Neils Quashie, Akosua Gyasi, Felicia Owusu-Antwi, Keziah Malm and Kwadwo Koram
Reference: 
Malaria Journal 2019 18:206, 24 June 2019

Routine surveillance on the therapeutic efficacy of artemisinin-based combination therapy (ACT) has been ongoing in Ghana since 2005. The sixth round of surveillance was conducted between 2015 and 2017 to determine the therapeutic efficacy of artesunate–amodiaquine (AS–AQ) and artemether–lumefantrine (AL) in 10 sentinel sites across the country.

Organization: 

High efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania

July 15, 2018 - 16:54 -- Open Access
Author(s): 
Celine I. Mandara, Reginald A. Kavishe, Deus S. Ishengoma, et al.
Reference: 
Malaria Journal 2018 17:261, 11 July 2018

These findings confirm high efficacy of the first- and the newly recommended alternative ACT for treatments for uncomplicated falciparum malaria in Tanzania.

Country: 

Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin

January 29, 2016 - 18:39 -- Open Access
Author(s): 
Aurore Ogouyèmi-Hounto, Christian Azandossessi, Souliatou Lawani, Georgia Damien, Yolande Sissinto Savi de Tove, Franck Remoue and Dorothée Kinde Gazard
Reference: 
Malaria Journal 2016 15:37, 22 January 2016

AL remains an efficacious drug for the treatment of uncomplicated falciparum malaria in Benin, although higher rates of re-infection remain a concern.

Country: 
Subscribe to RSS - artemether–lumefantrine (AL)